Innovation Pharmaceuticals Inc.
IPIX
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 18.00K | 18.00K | 18.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 18.00K | 18.00K | 18.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | 18.00K | 18.00K | 18.00K |
| SG&A Expenses | 1.49M | 1.48M | 1.78M | 1.99M | 2.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.36M | 2.94M | 3.64M | 4.45M | 6.14M |
| Operating Income | -2.36M | -2.94M | -3.62M | -4.44M | -6.12M |
| Income Before Tax | -2.62M | -3.17M | -4.11M | -4.90M | -6.41M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.62 | -3.17 | -4.11 | -4.90 | -6.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.62M | -3.17M | -4.11M | -4.90M | -6.41M |
| EBIT | -2.36M | -2.94M | -3.62M | -4.44M | -6.12M |
| EBITDA | -1.99M | -2.57M | -3.24M | -4.06M | -5.74M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 2.04B | 2.02B | 2.15B | 2.12B | 2.07B |
| Average Diluted Shares Outstanding | 2.04B | 2.02B | 2.15B | 2.12B | 2.07B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.83% | -2.71% | -1.70% | -1.43% | -0.59% |